PALM BEACH GARDENS, Fla.--(BUSINESS WIRE)--Aurora Diagnostics, a leading independent pathology services and cancer diagnostics company, today announced the acquisition of Cleveland Skin Pathology Laboratory Inc.
Founded in 1972, Cleveland Skin Pathology Laboratory is a physician-owned medical practice providing dermatopathology services to dermatologists, surgeons, and primary care providers, with concentration in the Midwest but with coast-to-coast reach. The practice has six board-certified dermatopathologists, who are also board-certified in pathology or dermatology. All of the doctors are committed academicians actively engaged within their specialty areas.
“We are very pleased to welcome the highly respected Cleveland Skin Pathology Laboratory team to our growing family of pathology practices,” said Daniel D. Crowley, President, Chairman and CEO of Aurora Diagnostics. “Their history of working in a collaborative environment and being available to discuss cases with referring clinicians is an approach that we appreciate and encourage at Aurora Diagnostics.”
“We are all excited to be part of the Aurora Diagnostics team,” said Jonathan Bass, MD, President of Cleveland Skin Pathology. “Aurora is an excellent cultural fit, with its commitment to community-based pathology practices. In addition, the company brings valuable resources dedicated to information technology, payor relations, human resources, and purchasing. We look forward to working with a team of committed colleagues and providing many more decades of diagnostic excellence to the physicians and patients we serve.”
Terms of the transaction were not disclosed.
About Aurora Diagnostics
Aurora Diagnostics is the leading independent anatomic pathology and cancer diagnostics company in the U.S. Its 29 community-based practices, with more than 200 board-certified pathologists, offer integrated diagnostic and personalized medicine consultations to thousands of physicians.
Referring physicians include dermatologists, obstetricians and gynecologists, family practitioners, gastroenterologists, urologists, general surgeons, and oncologists. Aurora pathologists provide diagnostic opinions and work collaboratively with them to determine appropriate patient treatment options.
Aurora Diagnostics is also a leader in hospital lab management services, supporting more than 100 hospitals throughout the country.
Additionally, the Company’s Aurora Research Institute subsidiary is a leader in helping hospitals and independent labs ethically provide tissue and blood samples to researchers on the cutting edge of research for effective cancer treatments.
For additional information regarding Aurora Diagnostics and the services it provides, please visit the company website at www.auroradx.com.
